These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24917087)

  • 1. The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry.
    O'Neill S; Sweeney J; Patterson CC; Menzies-Gow A; Niven R; Mansur AH; Bucknall C; Chaudhuri R; Thomson NC; Brightling CE; O'Neill C; Heaney LG;
    Thorax; 2015 Apr; 70(4):376-8. PubMed ID: 24917087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry.
    Sweeney J; Brightling CE; Menzies-Gow A; Niven R; Patterson CC; Heaney LG;
    Thorax; 2012 Aug; 67(8):754-6. PubMed ID: 22581823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budget impact analysis of a fixed-dose combination of fluticasone propionate and formoterol fumarate (FP/FORM) in a pressurized metered-dose inhaler (pMDI) for asthma.
    Dunlop W; Heron L; Fox G; Greaney M
    Adv Ther; 2013 Oct; 30(10):933-44. PubMed ID: 24194361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry.
    Sweeney J; Patterson CC; Menzies-Gow A; Niven RM; Mansur AH; Bucknall C; Chaudhuri R; Price D; Brightling CE; Heaney LG;
    Thorax; 2016 Apr; 71(4):339-46. PubMed ID: 26819354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct costs of overdiagnosed asthma: a longitudinal, population-based cohort study in British Columbia, Canada.
    Ng B; Sadatsafavi M; Safari A; FitzGerald JM; Johnson KM
    BMJ Open; 2019 Nov; 9(11):e031306. PubMed ID: 31699732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharma focus. Puff adders.
    Chapman S
    Health Serv J; 2003 Nov; 113(5883):suppl 6-7. PubMed ID: 14671867
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic costs for adult asthmatics according to severity and control status in Korean tertiary hospitals.
    Kim SH; Kim TW; Kwon JW; Kang HR; Lee YW; Kim TB; Kim SH; Park HW; Park SW; Chang YS; Cho YS; Park JW; Cho YJ; Yoon HJ; Cho SH; Choi BW; Moon HB; Min KU
    J Asthma; 2012 Apr; 49(3):303-9. PubMed ID: 22185405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care.
    Arnlind MH; Nokela M; Rehnberg C; Jonsson EW
    J Asthma; 2006 Oct; 43(8):585-91. PubMed ID: 17050222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare costs and resource utilization of asthma in Germany: a claims data analysis.
    Jacob C; Bechtel B; Engel S; Kardos P; Linder R; Braun S; Greiner W
    Eur J Health Econ; 2016 Mar; 17(2):195-201. PubMed ID: 25716136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada.
    Ismaila AS; Risebrough N; Li C; Corriveau D; Hawkins N; FitzGerald JM; Su Z
    Respir Med; 2014 Sep; 108(9):1292-302. PubMed ID: 25175480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population.
    Piecoro LT; Potoski M; Talbert JC; Doherty DE
    Health Serv Res; 2001 Jun; 36(2):357-71. PubMed ID: 11409817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma: resource use and costs for inhaled corticosteroid vs leukotriene modifier treatment--a meta-analysis.
    Halpern MT; Khan ZM; Stanford RH; Spayde KM; Golubiewski M
    J Fam Pract; 2003 May; 52(5):382-9. PubMed ID: 12737772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Economic cost of treating the patient with asthma in Spain: the AsmaCost study].
    Martínez-Moragón E; Serra-Batllés J; De Diego A; Palop M; Casan P; Rubio-Terrés C; Pellicer C;
    Arch Bronconeumol; 2009 Oct; 45(10):481-6. PubMed ID: 19525051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 36-month study on the cost/utility of add-on omalizumab in persistent difficult-to-treat atopic asthma in Italy.
    Dal Negro RW; Tognella S; Pradelli L
    J Asthma; 2012 Oct; 49(8):843-8. PubMed ID: 22954018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic impact of severe asthma in Spain: multicentre observational longitudinal study.
    Melero Moreno C; Quirce S; Huerta A; Uría E; Cuesta M
    J Asthma; 2019 Aug; 56(8):861-871. PubMed ID: 30003827
    [No Abstract]   [Full Text] [Related]  

  • 16. Budget busters.
    Cresswell J
    Community Nurse; 1999 Oct; 5(9):10. PubMed ID: 10732567
    [No Abstract]   [Full Text] [Related]  

  • 17. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.
    Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J
    J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis.
    Barry LE; Sweeney J; O'Neill C; Price D; Heaney LG
    Respir Res; 2017 Jun; 18(1):129. PubMed ID: 28651591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of severe asthma in Turkey: a cost of illness study from payer perspective.
    Bavbek S; Malhan S; Mungan D; Misirligil Z; Erdinc M; Gemicioglu B; Kivilcim Oguzulgen I; Oksuz E; Yildiz F; Yorgancioglu A
    Eur Ann Allergy Clin Immunol; 2021 May; 53(3):128-137. PubMed ID: 32372589
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of risk factors and health outcomes among persons with asthma.
    Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
    J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.